BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19856471)

  • 21. Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection.
    Hui CK; Lau E; Wu H; Monto A; Kim M; Luk JM; Lau GK; Wright TL
    J Clin Virol; 2006 Feb; 35(2):185-92. PubMed ID: 16103008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
    Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
    J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
    Kołtan S; Wysocki M; Kołtan A; Swiatkiewicz V; Styczyński J; Debski R; Balcar-Boroń A
    Med Sci Monit; 2002 Apr; 8(4):CR274-9. PubMed ID: 11951070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses.
    Oyunsuren T; Kurbanov F; Tanaka Y; Elkady A; Sanduijav R; Khajidsuren O; Dagvadorj B; Mizokami M
    J Med Virol; 2006 Dec; 78(12):1688-95. PubMed ID: 17063518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
    J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
    Zampino R; Marrone A; Karayiannis P; Cirillo G; del Giudice EM; Rania G; Utili R; Ruggiero G
    Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF
    Liver Int; 2009 Jan; 29 Suppl 1():100-7. PubMed ID: 19207972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection.
    Sezaki H; Kobayashi M; Hosaka T; Someya T; Akuta N; Suzuki F; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Sato J; Kumada H
    J Gastroenterol; 2004 Jun; 39(6):550-6. PubMed ID: 15235872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of chronic coinfection with hepatitis B and C virus on liver histology.
    Sagnelli E; Pasquale G; Coppola N; Scarano F; Marrocco C; Scolastico C; Santantonio T; Gentile A; Piccinino F
    Infection; 2004 Jun; 32(3):144-8. PubMed ID: 15188073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.
    Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M
    J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
    Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of viral activity in dual infection with hepatitis B and C in chronic liver disease.
    Guptan RC; Thakur V; Malhotra V; Sarin SK
    J Assoc Physicians India; 2002 May; 50(5):651-5. PubMed ID: 12186118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.
    Marcellin P; Pequignot F; Delarocque-Astagneau E; Zarski JP; Ganne N; Hillon P; Antona D; Bovet M; Mechain M; Asselah T; Desenclos JC; Jougla E
    J Hepatol; 2008 Feb; 48(2):200-7. PubMed ID: 18086507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.